NIH | National Cancer Institute | NCI Wiki  

WIKI MAINTENANCE NOTICE

Please be advised that NCI Wiki will be undergoing maintenance Monday, July 22nd between 1700 ET and 1800 ET and will be unavailable during this period.
Please ensure all work is saved before said time.

If you have any questions or concerns, please contact the CBIIT Atlassian Management Team.

Versions Compared

Old Version 5

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

compared with

New Version Current

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Removed “v1” from one or more https://clinicaltrialsapi.cancer.gov links.

...

If you import an Expanded Access trial from ClinicalTrials.gov (whether via the Registration or PA web application), the system automatically sets this value to Yes. Otherwise, the default is No. The system does not include this attribute in the TSR, in the XML output to ClinicalTrials.gov, in the trial data sent to Cancer.gov, or in the set of trials provided to the NCI Clinical Trials API. 

When a trial has trial is listed as Expanded Access at the trial level in CTRP, the Expanded Access use of the drug/device will most likely require be required by another interventional trial with an IND/IDE that is Available for Expanded Access. For instructions on configuring the separate Expanded Access fields for the trial with an as part of the IND/IDE for a trial, refer to to Abstracting INDs and IDEs. Consider also Also, consider specifying each of these trials as an Associated Trial for the other. For instructions, refer to Associating Trials.